These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 33023856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
    Carvelli J, Demaria O, Vély F, Batista L, Chouaki Benmansour N, Fares J, Carpentier S, Thibult ML, Morel A, Remark R, André P, Represa A, Piperoglou C, Explore COVID-19 IPH group, Explore COVID-19 Marseille Immunopole group, Cordier PY, Le Dault E, Guervilly C, Simeone P, Gainnier M, Morel Y, Ebbo M, Schleinitz N, Vivier E.
    Nature; 2020 Dec; 588(7836):146-150. PubMed ID: 32726800
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cell-Free Therapies: Novel Approaches for COVID-19.
    Maron-Gutierrez T, Rocco PRM.
    Front Immunol; 2020 Dec; 11():583017. PubMed ID: 33072130
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
    Chang FY, Chen HC, Chen PJ, Ho MS, Hsieh SL, Lin JC, Liu FT, Sytwu HK.
    J Biomed Sci; 2020 Jun 04; 27(1):72. PubMed ID: 32498686
    [Abstract] [Full Text] [Related]

  • 11. [Not Available].
    Fumeaux T.
    Rev Med Suisse; 2020 Nov 11; 16(714):2190. PubMed ID: 33174705
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP.
    Vaccine; 2020 Jun 26; 38(31):4783-4791. PubMed ID: 32507409
    [Abstract] [Full Text] [Related]

  • 14. [Not Available].
    Meylan P.
    Rev Med Suisse; 2020 Nov 11; 16(714):2190-2191. PubMed ID: 33174706
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug targets for COVID-19 therapeutics: Ongoing global efforts.
    Saxena A.
    J Biosci; 2020 Nov 11; 45(1):. PubMed ID: 32661214
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.